EPISODE · Oct 20, 2020 · 43 MIN
Netflix Shares Drop After Earnings, and the Top Biotech Analyst Dissects the Race for a COVID Cure
from CNBC's "Fast Money" · host CNBC
Netflix stock dropped after the company posted disappointing subscriber growth and earnings for the latest quarter. Plus results from Snap and Texas Instruments. And Institutional Investor’s Top-Rated Biotech Analyst breaks down the outlook for companies racing to bring a coronavirus vaccine to market. And a moment of zen for Kohl’s as the department store takes on a new project. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
What this episode covers
Netflix stock dropped after the company posted disappointing subscriber growth and earnings for the latest quarter. Plus results from Snap and Texas Instruments. And Institutional Investor’s Top-Rated Biotech Analyst breaks down the outlook for companies racing to bring a coronavirus vaccine to market. And a moment of zen for Kohl’s as the department store takes on a new project.
NOW PLAYING
Netflix Shares Drop After Earnings, and the Top Biotech Analyst Dissects the Race for a COVID Cure
No transcript for this episode yet
Similar Episodes
Apr 29, 2025 ·12m
Apr 27, 2025 ·11m
Apr 24, 2025 ·11m
Apr 22, 2025 ·14m